blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3240554

EP3240554 - BLAUTIA STERCOSIS AND WEXLERAE FOR USE IN TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES [Right-click to bookmark this link]
Former [2017/45]COMPOSITIONS COMPRISING BACTERIAL STRAINS
[2018/38]
StatusPatent revoked
Status updated on  08.12.2023
Database last updated on 03.04.2025
FormerThe patent has been granted
Status updated on  28.06.2019
FormerGrant of patent is intended
Status updated on  23.04.2019
FormerExamination is in progress
Status updated on  06.04.2019
FormerGrant of patent is intended
Status updated on  11.02.2019
FormerExamination is in progress
Status updated on  14.12.2018
FormerGrant of patent is intended
Status updated on  09.10.2018
FormerExamination is in progress
Status updated on  12.01.2018
FormerRequest for examination was made
Status updated on  06.10.2017
FormerThe international publication has been made
Status updated on  23.12.2016
Most recent event   Tooltip21.03.2025Lapse of the patent in a contracting state
New state(s): SM		published on 23.04.2025 [2025/17]
Applicant(s)For all designated states
CJ Bioscience, Inc.
7F, B, 14, Sejong-daero
Jung-gu
Seoul 04527 / KR
[2023/49]
Former [2017/45]For all designated states
4D Pharma Research Limited
Life Sciences Innovation Building
Cornhill Road
Aberdeen, Aberdeenshire AB25 2ZS / GB
Inventor(s)01 / GRANT, George
Life Sciences Innovation Building
Cornhill Road
Aberdeen Aberdeenshire AB25 2ZS / GB
02 / PATTERSON, Angela Margaret
Norwich Medical School
Faculty of Medicine and Health Sciences
University of East Anglia
Norwich East Anglia NR4 7JT / GB
03 / MULDER, Imke
Life Sciences Innovation Building
Cornhill Road
Aberdeen Aberdeenshire AB25 2ZS / GB
04 / MCCLUSKEY, Seanin
c/o 4D PHARMA PLC
3rd Floor 9 Bond Court
Leeds West Yorkshire LS1 2JZ / GB
05 / RAFTIS, Emma
c/o 4D PHARMA PLC
3rd Floor 9 Bond Court
Leeds West Yorkshire LS1 2JZ / GB
 [2017/45]
Representative(s)Bates, Philip Ian, et al
Reddie & Grose LLP The White Chapel Building
10 Whitechapel High Street
London E1 8QS / GB
[N/P]
Former [2019/31]Marshall, Cameron John
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
Former [2017/45]Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
Application number, filing date16731640.515.06.2016
[2017/45]
WO2016GB51770
Priority number, dateGB2015001046615.06.2015         Original published format: GB 201510466
GB2015002050820.11.2015         Original published format: GB 201520508
GB2016000681019.04.2016         Original published format: GB 201606810
[2017/45]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016203218
Date:22.12.2016
Language:EN
[2016/51]
Type: A1 Application with search report 
No.:EP3240554
Date:08.11.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 22.12.2016 takes the place of the publication of the European patent application.
[2017/45]
Type: B1 Patent specification 
No.:EP3240554
Date:31.07.2019
Language:EN
[2019/31]
Search report(s)International search report - published on:EP22.12.2016
ClassificationIPC:A61K35/74, C12N1/20, A61P1/00, A61P11/06, A61P29/00, A61P19/02, A61P25/28, A61K35/745
[2018/38]
CPC:
A61K35/74 (EP,CN,KR,US); A61K35/747 (KR,US); A23L33/135 (CN);
A61P1/00 (EP); A61P1/02 (EP); A61P1/04 (EP);
A61P11/00 (EP); A61P11/02 (EP); A61P11/06 (EP,KR);
A61P11/16 (EP); A61P17/00 (EP); A61P17/02 (EP);
A61P17/06 (EP); A61P19/00 (EP); A61P19/02 (EP);
A61P25/00 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P27/14 (EP); A61P29/00 (EP,CN,KR); A61P35/00 (EP,KR);
A61P37/00 (EP); A61P37/02 (CN); A61P37/06 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P9/10 (EP);
A61P9/14 (EP); C07K14/54 (KR,US); C07K16/24 (KR,US);
C12N1/205 (EP,CN,US); A23V2002/00 (CN); A61K2035/11 (KR);
A61K38/00 (EP,US); C12R2001/01 (EP,CN,KR,US) (-)
C-Set:
A23V2002/00, A23V2200/30 (CN)
Former IPC [2017/45]A61K35/74, C12N1/20, A61P1/00, A61P11/06, A61P29/00, A61P19/02, A61P25/28, A61P35/00, A61K35/745
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/45]
Extension statesBA02.08.2017
ME02.08.2017
Validation statesMA02.08.2017
MD02.08.2017
TitleGerman:BLAUTIA STERCOSIS UND WEXLERAE ZUR VERWENDUNG IN DER BEHANDLUNG VON ENTZÜNDLICHEN UND AUTOIMMUNEN ERKRANKUNGEN[2018/38]
English:BLAUTIA STERCOSIS AND WEXLERAE FOR USE IN TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES[2018/38]
French:BLAUTIA STERCOSIS ET WEXLERAE POUR L'UTILISATION DANS LE TRAITEMENT DES MALADIES INFLAMMATOIRES ET AUTO-IMMUNES.[2018/38]
Former [2017/45]ZUSAMMENSETZUNGEN MIT BAKTERIENSTÄMMEN
Former [2017/45]COMPOSITIONS COMPRISING BACTERIAL STRAINS
Former [2017/45]COMPOSITIONS COMPRENANT DES SOUCHES BACTÉRIENNES
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase02.08.2017National basic fee paid 
02.08.2017Designation fee(s) paid 
02.08.2017Examination fee paid 
Examination procedure02.08.2017Amendment by applicant (claims and/or description)
02.08.2017Examination requested  [2017/45]
02.08.2017Date on which the examining division has become responsible
15.01.2018Despatch of a communication from the examining division (Time limit: M04)
25.05.2018Reply to a communication from the examining division
10.10.2018Communication of intention to grant the patent
12.12.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
12.02.2019Communication of intention to grant the patent
03.04.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
24.04.2019Communication of intention to grant the patent
18.06.2019Fee for grant paid
18.06.2019Fee for publishing/printing paid
18.06.2019Receipt of the translation of the claim(s)
Divisional application(s)EP19189140.7  / EP3636272
Opposition(s)Opponent(s)01  30.04.2020  08.05.2020  ADMISSIBLE
Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
Opponent's representative
Hoffmann Eitle, et al, et al
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
 [2021/15]
Former [2020/24]
Opponent(s)01  30.04.2020    ADMISSIBLE
Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
Opponent's representative
Hoffmann Eitle, et al, et al
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
deletedDeletion: Legal effect of rejection of opposition [ N /P ]
22.06.2020Invitation to proprietor to file observations on the notice of opposition
02.11.2020Reply of patent proprietor to notice(s) of opposition
02.03.2022Date of oral proceedings
04.04.2022Despatch of minutes of oral proceedings
04.04.2022Date of despatch of rejection of opposition
30.11.2023Legal effect of revocation of patent [2024/02]
30.11.2023Despatch of communication that the patent will be revoked
Appeal following opposition08.06.2022Appeal received No.  T1436/22
08.06.2022Payment of appeal fee
16.08.2022Statement of grounds filed
27.11.2023Result of appeal procedure: REVOCATION OF PATENT AT PROPRIETOR'S REQUEST
30.11.2023Despatch of the decision of the Board of Appeal
Fees paidRenewal fee
11.06.2018Renewal fee patent year 03
13.06.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Stay/Interruption17.03.2023Interruption of proceedings. Reason: legal prevention of applicant[2023/30]
02.11.2023Resumption of proceedings[2023/33]
17.03.2023Interruption of proceedings. Reason: legal prevention of applicant[2023/33]
Lapses during opposition  TooltipRS15.06.2016
BG15.06.2023
CZ15.06.2023
HR15.06.2023
IE15.06.2023
LV15.06.2023
RO15.06.2023
SI16.06.2023
DK30.06.2023
EE30.06.2023
MC30.06.2023
NO30.06.2023
SM30.06.2023
[2025/17]
Former [2025/10]RS15.06.2016
BG15.06.2023
CZ15.06.2023
HR15.06.2023
IE15.06.2023
LV15.06.2023
RO15.06.2023
SI16.06.2023
DK30.06.2023
EE30.06.2023
MC30.06.2023
NO30.06.2023
Former [2025/07]BG15.06.2023
CZ15.06.2023
HR15.06.2023
IE15.06.2023
LV15.06.2023
RO15.06.2023
RS15.06.2023
SI16.06.2023
DK30.06.2023
EE30.06.2023
MC30.06.2023
NO30.06.2023
Former [2024/51]BG15.06.2023
CZ15.06.2023
HR15.06.2023
IE15.06.2023
LV15.06.2023
RO15.06.2023
RS15.06.2023
SI16.06.2023
DK30.06.2023
EE30.06.2023
NO30.06.2023
Former [2024/50]CZ15.06.2023
HR15.06.2023
IE15.06.2023
LV15.06.2023
RO15.06.2023
RS15.06.2023
SI16.06.2023
DK30.06.2023
EE30.06.2023
NO30.06.2023
Former [2024/46]CZ15.06.2023
HR15.06.2023
LV15.06.2023
RO15.06.2023
RS15.06.2023
SI16.06.2023
DK30.06.2023
EE30.06.2023
NO30.06.2023
Former [2024/24]CZ15.06.2023
HR15.06.2023
LV15.06.2023
RO15.06.2023
RS15.06.2023
SI16.06.2023
EE30.06.2023
NO30.06.2023
Former [2024/10]CZ15.06.2023
LV15.06.2023
RO15.06.2023
RS15.06.2023
Cited inInternational search[XY]US2003147858  (RENAUD MICHEL [FR], et al);
 [XY]US2014199281  (HENN MATTHEW R [US], et al);
 [XY]WO2014121298  (SERES HEALTH INC [US]);
 [XY]US2014341921  (HONDA KENYA [JP], et al);
 [XY]WO2014201037  (UNIV NEW YORK [US])
OppositionWO2014121304
 WO2014201037
 WO2015095241
 WO2016086210
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.